SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005808
Filing Date
2024-02-12
Accepted
2024-02-12 06:30:32
Documents
15
Period of Report
2024-02-09
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46881
  Complete submission text file 0001493152-24-005808.txt   267791

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldi-20240209.xsd EX-101.SCH 3813
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldi-20240209_def.xml EX-101.DEF 26683
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cldi-20240209_lab.xml EX-101.LAB 36817
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldi-20240209_pre.xml EX-101.PRE 25307
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5885
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40789 | Film No.: 24617307
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)